Pharmacology For Podiatrists Quiz! Exam

53 Questions | Total Attempts: 724

SettingsSettingsSettings
Pharmacology For Podiatrists Quiz! Exam - Quiz

A Podiatrist is a medication practitioner who deals with issues that affect the parts of the leg. They diagnose such issues and give medicine. Being that you are an aspiring podiatrist, how well do you know the type of medication to prescribe to your patients? Take this pharmacology quiz that has perfect questions on that and get to find out.


Questions and Answers
  • 1. 
    A type of diffusion that usually occurs is within larger body compartments (interstitial space, cytosol) and across epithelial membrane tight junctions and through pores in blood vessel endothelial lining.
    • A. 

      Lipid effusion

    • B. 

      Aqueous diffusion

    • C. 

      Carrier-mediated

    • D. 

      Endocytosis

    • E. 

      Exocytosis

  • 2. 
    Pharmacodynamics is the study of the:
    • A. 

      Toxic effects of drugs

    • B. 

      Absorption, distribution, metabolism and excretion of drugs

    • C. 

      Mechanism of action of drugs

    • D. 

      Formation of drugs

  • 3. 
    Which of the following drugs acts by a non-specific physicochemical mechanism?
    • A. 

      A bulk laxative

    • B. 

      A histamine H2-antagonist

    • C. 

      A cyclooxygenase inhibitor

    • D. 

      A B2-adrenoceptor agonist

  • 4. 
    The molecular target for sildenafil (viagra) is
    • A. 

      Guanylate cyclase

    • B. 

      Phosphodiesterase type 5

    • C. 

      Angiotensim converting enzyme

    • D. 

      Cyclooxygenase

  • 5. 
    Nifedipine can be used to lower systemic arterial hypertension because it blocks:
    • A. 

      Potassium channels

    • B. 

      Sodium channels

    • C. 

      Calcium channels

    • D. 

      Chloride channels

  • 6. 
    Which of the following drugs are potassium channel openers?
    • A. 

      Verapamil

    • B. 

      Minoxidil

    • C. 

      Indomethacin

    • D. 

      Lidocaine

  • 7. 
    Which of these is a sodium channel blocker?
    • A. 

      Verapamil

    • B. 

      Minoxidil

    • C. 

      Indomethacin

    • D. 

      Lidocaine

  • 8. 
    Prazosin is a receptor anatagonist at the:
    • A. 

      M2 muscarinic receptor

    • B. 

      Alpha 1 adrenoceptor

    • C. 

      Beta 2 bradykinin receptor

    • D. 

      5-HT2a receptors

  • 9. 
    Captopril blocks the enzyme.
    • A. 

      Tyrosine hydroxylase

    • B. 

      Acetylcholinesterase

    • C. 

      Angiotension converting enzyme

    • D. 

      Renin

  • 10. 
    Bendrofluazide acts as:
    • A. 

      A receptor anatagonist at the alpha 1 adrenoceptors

    • B. 

      A receptor anatagonist at the acetylcholine nicotinic receptor

    • C. 

      A diurectic

    • D. 

      An ace inhibitor

  • 11. 
    Losartan is
    • A. 

      An ACE inhibitor

    • B. 

      An angiotensin 2 receptor antagonist

    • C. 

      A Beta adrenoceptor anatagonist (beta blocker)

    • D. 

      A calcium channel blocker

  • 12. 
    Tirofiban is used to prevent the formation of an arterial white thrombus because it
    • A. 

      Blocks the glycoprotein GP Ib on platelets

    • B. 

      Blocks the enzyme cyclooxygenase in platelets to inhibit the production of thromboxane

    • C. 

      Blocks the enzyme nitric oxide synthase on the endothelium to inhibit the production of nitric oxide

    • D. 

      Blocks glycoprotein receptor GP IIa- IIIb on platelets

  • 13. 
    Streptokinase is used in the treatment of thrombosis because it
    • A. 

      Inhibits the conversion of prothrombin to thrombin

    • B. 

      Increase the conversion of protein C to activated protein C

    • C. 

      Increase the conversion of plasminogen to plasmin

    • D. 

      Inhibit the polymerization of fibrin

  • 14. 
    Heprin
    • A. 

      Inhibit the formation of vit K dependent coagulation factors

    • B. 

      Acts as a catalyst in the reaction between thrombin and thrombomodulin

    • C. 

      Inhibits platlets

    • D. 

      Acts as catalyst in the reaction between thrombin and antithrombin III

  • 15. 
    The coagulation cofactors (vIII & V) are important in fibrin formation because
    • A. 

      They are proteolytic

    • B. 

      They accelerate coagulation by more than 100,000 fold

    • C. 

      They inactivate by ATIII

    • D. 

      They are inactivated by heprin

  • 16. 
    Oral formulation
    • A. 

      Are subject to first pass metabolism

    • B. 

      May have delayed absorption due to presence of food

    • C. 

      If acidic, are best absorbed from stomach

    • D. 

      Are more slowly absorbed than rectal formulation

  • 17. 
    Which of the following is/are located in the cell?
    • A. 

      Channel-linked (ionotropic) receptors

    • B. 

      G-protein coupled (metabotropic) receptors

    • C. 

      Kinase- linked receptors

    • D. 

      Receptors for steriod hormones

  • 18. 
    The following are examples of inotropic receptors:
    • A. 

      Insulin receptors

    • B. 

      Acetylcholine muscarinic receptors

    • C. 

      Beta- adrenoceptors

    • D. 

      Acetylcholine nicotinic receptors

  • 19. 
    A reversible competitive antagonist can have the following effect on an agonist concentration-response curve:
    • A. 

      Shift to the right

    • B. 

      Shift to the left

    • C. 

      No change in slope and maximum response

    • D. 

      Reduction in slope and maximum response

  • 20. 
    Cardiac ouput is
    • A. 

      Approx 5.5l/min

    • B. 

      Approx 70ml/min

    • C. 

      HR X SV

    • D. 

      HR/SV

  • 21. 
    Stroke volume =
    • A. 

      EDV-ESV

    • B. 

      ESV-EDV

    • C. 

      CO/HR

    • D. 

      HR/CO

  • 22. 
    The coagulation cofactors VIII & V.
    • A. 

      Are activated by thrombin

    • B. 

      Accelerated the activity of factor IXa and Xa

    • C. 

      Are inactivated the APC system

    • D. 

      Are inactivated by TFPI

  • 23. 
    Noradrenaline can increase TPR by:
    • A. 

      Constricting veins

    • B. 

      Constricting arterioles

    • C. 

      Acting on the beta-adrenoceptors

    • D. 

      Acting on alpha-adrenoceptors

  • 24. 
    Warfarin
    • A. 

      Is not used during pregnancy

    • B. 

      Cannot be taken orally

    • C. 

      In a vitamin K anatagonist

    • D. 

      Is a fibrinolytic agent

  • 25. 
    Diuretics are use in blood pressure control because they:
    • A. 

      Increase cardiac output

    • B. 

      Decrease cardiac output

    • C. 

      Increase plamsa sodium

    • D. 

      Decrease plasma sodium